Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: A pilot animal study

Journal of Ultrasound in Medicine

Volumn 24, Issue 7, 2005, Pages 975-983

  Li, Jie ^a   Dong, Bao Wei ^b   Yu, Xiao Ling ^b   Wang, Xing Hua ^c   Li, Chuan Fu ^a  

^a SHANDONG UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Contrast media; Liver neoplasms; Liver tumor; Ultrasonography

Indexed keywords

BIODIVERSITY; BIOLOGICAL ORGANS; DIAGNOSIS; HEMODYNAMICS; PARAMETER ESTIMATION; SIGNAL PROCESSING; TUMORS;

PARENCHYMA; SIGNAL INTENSITY; ULTRASONOGRAPHY;

ULTRASONICS;

SONOVUE; SULFUR HEXAFLUORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CARCINOGENESIS; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEMODYNAMICS; IN VIVO STUDY; LIVER PARENCHYMA; LIVER SCINTISCANNING; LIVER TUMOR; NONHUMAN; RABBIT; TUMOR VASCULARIZATION;

EID: 21244473072     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2005.24.7.975     Document Type: Article

References (25)

1. Ohashi I, Hanafusa K, Yoshida T. Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation. Radiology 1993; 189:851-855.
2. Kim T, Murakami T, Hori M, et al. Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking. AJR Am J Roentgenol 2002; 178:899-904.
3. Torzilli G, Olivari N, Moroni E, et al. Contrast-enhanced intraoperative ultrasonography in surgery for hepatocellular carcinoma in cirrhosis. Liver Transpl 2004; 10(suppl 1):S34-S38.
4. Bartolozzi C, Lencioni R, Ricci P, Paolicchi A, Rossi P, Passanello R. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 1998; 209:387-393.
5. Kono Y, Moriyasu F, Nada T, et al. Gray-scale second harmonic imaging of the liver: a preliminary animal study. Ultrasound Med Biol 1997; 23:719-726.
6. Hirokawa T, Nishikage T, Moroe T, et al. Visualization of uveal perfusion by contrast-enhanced harmonic ultrasonography at a low mechanical index: a pilot animal study. J Ultrasound Med 2002; 21:299-307.
7. Seidel G, Vidal-Langwasser M, Algermissen C, Gerriets T, Kaps M. The influence of Doppler system settings on the clearance kinetics of different ultrasound contrast agents. Eur J Ultrasound 1999; 9: 167-175.
8. Cosgrove D. Ultrasound contrast enhancement of tumors. Clin Radiol 1996; 51(suppl 1):44-49.
9. Blomley M, Albrecht T, Cosgrove D, Jayaram V, Butler-Barnes J, Eckersley R. Stimulated acoustic emission in liver parenchyma with Levovist. Lancet 1998; 351:568.
10. Maruyama H, Matsutani S, Saisho H, Mine Y, Yuki H, Miyata K. Extra-low acoustic power harmonic images of the liver with perflutren. J Ultrasound Med 2003; 22:931-938.
11. Krix M, Kiessling F, Essig M, et al. Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography. Invest Radiol 2004; 39:216-222.
12. Dill-Macky MJ, Burns PN, Khalili K, Wilson ST. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002; 222:95-105.
13. Maruyama H, Matsutani S, Saisho H, Kamiyama N, Yuki H, Miyata K. Grey-scale contrast enhancement in rabbit liver with DMP115 at different acoustic power levels. Ultrasound Med Biol 2000; 26:1429-1438.
14. Spiezia S, Farina R, Cerbone G, et al. Analysis of color Doppler signal intensity variation after Levovist injection: a new approach to the diagnosis of thyroid nodules. J Ultrasound Med 2001; 20:223-231.
15. Maresca G, Summaria V, Colagrande C, Manfredi R, Calliada F. New prospects for ultrasound contrast agents. Eur J Radiol 1998; 27(suppl 2):S171-5178.
16. Kim KW, Choi BI, Park SH, et al. Hepatocellular carcinoma: assessment of vascularity with single-level dynamic ultrasonography during the arterial phase. J Ultrasound Med 2003; 22:887-896.
17. Bernatik T, Becker D, Neureiter D, et al. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol 2004; 16:313-317.
18. Koda M, Matsunaga Y, Ueki M, et al. Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound. Eur Radiol 2004; 14:1100-1108.
19. Kopka L, Rodenwaldt J, Fischer U, Mueller DW, Oestmann DW, Grabbe E. Dual-phase helical CT of the liver: effects of bolus tracking and different volumes of contrast material. Radiology 1996; 201: 321-326.
20. Catalano O, Sandomenico F, Raso MM, Siani A. Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses. AJR Am J Roentgenol 2004; 182:447-450.
21. Li J, Li CF. Color Doppler study of fasting and postprandial hemodynamic changes in the hepatic artery and portal vein in healthy subjects. Chin J Ultrasound Med 2001; 17:367-369.
22. Leen E, Goldberg JA, Robertson J, et al. Detection of hepatic metastases using duplex/color Doppler sonography. Ann Surg 1991; 214:599-604.
23. Shuman WP. Liver metastases from colorectal carcinoma: detection with Doppler US-guided measurements of liver blood flow-past, present, future. Radiology 1995; 195:9-10.
24. Blomley MJK, Albrecht T, Cosgrove DO, et al. Liver vascular transmit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology 1998; 209:862-866.
25. Taylor KJ, Ramos I, Carter D, Morse SS, Snower D, Fortune K. Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology 1988; 166:57-62.